BRANDI BULLS: Open Payments
NPI 1417088667 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 21 payments from 14 companies in 2025. Trend: 2023 $387 · 2024 $422 · 2025 $504
Food & beverage: $427Education: $77
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 1 | $77 |
| Axsome Therapeutics, Inc. | 2 | $62 |
| Alexion Pharmaceuticals, Inc. | 2 | $57 |
| Eisai Inc. | 2 | $52 |
| Neurocrine BioSciences, Inc. | 3 | $44 |
| Biogen, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Lundbeck LLC | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
Products named: Leqembi, ULTOMIRIS, INGREZZA, ACTHAR, HYQVIA, Sunosi, Symbravo, REXULTI.
Industry payments across TX — which companies pay providers there.
